SA PRO
Free Account
Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 94% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
94%
Rating Distribution
Strong Buy
00%
Buy
1594%
Hold
16%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 36% higher.

Bear Case
$33.00
+36%
Consensus
$33.00
+36%
Bull Case
$33.00
+36%
Price Range16 analysts
Low
Consensus
High
$33.00
$33.00
Current Target
Current Price
$24.30
Upside to Target
$8.70

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 7, 2025Oppenheimer
Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
Target:$33.00
+52.4%from $21.66
Mar 3, 2025Robert W. Baird
Catalyst Pharmaceuticals price target raised to $32 from $28 at Baird
Target:$32.00
+43.4%from $22.32
Feb 4, 2025Robert W. Baird
Catalyst Pharmaceuticals initiated with an Outperform at Baird
Target:$28.00
+21.3%from $23.09
Jan 10, 2025H.C. Wainwright
Catalyst Pharmaceuticals price target raised to $35 from $30 at H.C. Wainwright
Target:$35.00
+59.7%from $21.92
Dec 21, 2022Truist Financial
Truist Securities Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $18
Target:$18.00
-6.0%from $19.15
Dec 21, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $24
Target:$24.00
+29.0%from $18.60
Dec 19, 2022Piper Sandler
Catalyst Pharmaceuticals price target raised to $20 from $18 at Piper Sandler
Target:$20.00
+21.9%from $16.41
Aug 24, 2022Roth Capital
Catalyst Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Target:$15.50
+4.0%from $14.91
Aug 11, 2022Truist Financial
Truist Securities Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $17
Target:$17.00
+26.3%from $13.46
Aug 11, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $18
Target:$18.00
+37.1%from $13.13

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance